Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 12 of 43, showing 5 Applications out of 212 total, starting on record 56, ending on 60

# Protocol No Study Title Investigator(s) & Site(s)

56.

ECCT/25/08/01   MK-8527 as HIV-1 PrEP in Women
    A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure   Prophylaxis in Women       
Principal Investigator(s)
1. Maricianah Onono
Site(s) in Kenya
1. KEMRI-RCTP KISUMU (Kisumu county)
2. Kargeno Research and Policy Hub KEMRI-CMR KISUMU (Kisumu county)
3. KEMRI-PHRD, Thika (Kiambu county)
4. UW KNH - Rachuonyo County Hospital (Homa Bay county)
 
View

57.

ECCT/08/08/02  
    Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition within HIV-1 Discordant Couples   
Principal Investigator(s)
1. Edwin Onyango Were
Site(s) in Kenya
1. Eldoret Site (Uasin Gishu county)
2. Kisumu Site (Kisumu county)
3. Thika Site (Kiambu county)
4. Nairobi Site (Nairobi City county)
 
View

58.

ECCT/24/06/04   ALNASA
    A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE       
Principal Investigator(s)
1. Jacqueline Mirera
Site(s) in Kenya
1. Clinical Research Health Network (CREA-N) (Machakos county)
 
View

59.

ECCT/13/04/09   Short-course RPT/INH for latent TB in HIV-infected individuals
        Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Deborah C. Langat
Site(s) in Kenya
1. Kenya Medical Research Institute Walter Reed Project Clinical Research Centre (Kericho county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
 
View

60.

ECCT/15/08/01   Rifapentine During Intensive Phase TB Treatment
     Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: a randomized, open-label, controlled, phase 3 clinical trial   
Principal Investigator(s)
1. Elisha Ochieng Okeyo
Site(s) in Kenya
KEMRICDC, KISUMU, KENYA
 
View